The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality-Reference-Cited by-同舟云学术

The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality

Published:2021-05-01 Issue:9 Volume:203 Page:1149-1157
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Sanders Jason L.¹^ORCID,Putman Rachel K.¹,Dupuis Josée²,Xu Hanfei²,Murabito Joanne M.³⁴,Araki Tetsuro⁵,Nishino Mizuki⁵,Benjamin Emelia J.³⁴,Levy Daniel L.³⁴,Ramachandran Vasan S.³⁴,Washko George R.¹,Curtis Jeffrey L.⁶⁷^ORCID,Freeman Christine M.⁶⁸,Bowler Russell P.⁹,Hatabu Hiroto⁵¹⁰,O’Connor George T.¹¹¹²,Hunninghake Gary M.¹¹⁰

Affiliation:

1. Division of Pulmonary and Critical Care Medicine and

2. Department of Biostatistics, School of Public Health

3. Department of Medicine, and

4. Framingham Heart Study, Framingham, Massachusetts

5. Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts

6. Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan

7. Medical Service and

8. Research Service, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan

9. Department of Medicine, National Jewish Health–Health Sciences Center, University of Colorado at Denver, Denver, Colorado

10. Center for Pulmonary Functional Imaging, Brigham and Women’s Hospital–Harvard Medical School, Harvard University, Boston, Massachusetts; and

11. Pulmonary Center, School of Medicine, Boston University, Boston, Massachusetts

12. Division of Pulmonary, Allergy, Sleep, and Critical Care Medicine, Boston Medical Center, Boston, Massachusetts

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference49 articles.

1. A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup

2. Pathogenesis of Idiopathic Pulmonary Fibrosis

3. The Aging Lung and Idiopathic Pulmonary Fibrosis

4. Why Does an Aging Smoker’s Lung Develop Idiopathic Pulmonary Fibrosis and Not Chronic Obstructive Pulmonary Disease?

5. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis;American Journal of Respiratory and Critical Care Medicine;2024-09-01

2. Benefit delayed immunosenescence by regulating CD4⁺T cells: A promising therapeutic target for aging‐related diseases;Aging Cell;2024-08-18

3. Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts;American Journal of Respiratory and Critical Care Medicine;2024-08-15

4. SenNet recommendations for detecting senescent cells in different tissues;Nature Reviews Molecular Cell Biology;2024-06-03

5. Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study;American Journal of Respiratory and Critical Care Medicine;2024-05-01